BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27575475)

  • 1. A novel lead of P-selectin inhibitor: Discovery, synthesis, bioassays and action mechanism.
    Wu J; Zhao M; Wang Y; Wang Y; Zhu H; Zhao S; Peng S
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4631-4636. PubMed ID: 27575475
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Wu J; Zhao M; Wang Y; Wang Y; Zhu H; Zhao S; Gui L; Zhang X; Peng S
    Drug Des Devel Ther; 2017; 11():225-239. PubMed ID: 28176928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrolo[1,2:4,5]-1,4-dioxopyrazino[1,2:1,6]pyrido[3,4-b]indoles: a group of urokinase inhibitors, their synthesis, and stereochemistry-dependent activity.
    Liu J; Wang Y; Yang Y; Jiang X; Zhao M; Wang W; Wu G; Wu J; Zheng M; Peng S
    ChemMedChem; 2011 Dec; 6(12):2312-22. PubMed ID: 21953864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles of a New Small-Molecule P-Selectin Inhibitor Attenuate Thrombosis, Inflammation, and Tumor Growth in Two Animal Models.
    Feng Q; Wang M; Muhtar E; Wang Y; Zhu H
    Int J Nanomedicine; 2021; 16():5777-5795. PubMed ID: 34471352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new class of anti-thrombosis hexahydropyrazino-[1',2':1,6]pyrido-[3,4-b]-indole-1,4-dions: design, synthesis, logK determination, and QSAR analysis.
    Liu J; Wu G; Cui G; Wang WX; Zhao M; Wang C; Zhang Z; Peng S
    Bioorg Med Chem; 2007 Sep; 15(17):5672-93. PubMed ID: 17590343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
    Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
    Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-oxidant ebselen delays microvascular thrombus formation in the rat cremaster muscle by inhibiting platelet P-selectin expression.
    Lindenblatt N; Schareck W; Belusa L; Nickels RM; Menger MD; Vollmar B
    Thromb Haemost; 2003 Nov; 90(5):882-92. PubMed ID: 14597984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased venous thrombosis with an oral inhibitor of P selectin.
    Myers DD; Rectenwald JE; Bedard PW; Kaila N; Shaw GD; Schaub RG; Farris DM; Hawley AE; Wrobleski SK; Henke PK; Wakefield TW
    J Vasc Surg; 2005 Aug; 42(2):329-36. PubMed ID: 16102635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo.
    Xu X; Wang Y; Wu J; Hu X; Zhu H; Zhang X; Wang Y; Gui L; Zhao M; Peng S
    Int J Nanomedicine; 2017; 12():4415-4431. PubMed ID: 28652742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of action.
    Yang G; Zhu H; Zhao M; Wu J; Wang Y; Wang Y; Zheng M; Chen M; Liu J; Peng S
    Mol Biosyst; 2012 Oct; 8(10):2672-9. PubMed ID: 22801714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent 1,3-disubstituted-9H-pyrido[3,4-b]indoles as new lead compounds in antifilarial chemotherapy.
    Srivastava SK; Agarwal A; Chauhan PM; Agarwal SK; Bhaduri AP; Singh SN; Fatima N; Chatterjee RK
    J Med Chem; 1999 May; 42(9):1667-72. PubMed ID: 10229635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent.
    Zhu H; Wang Y; Song C; Feng Q; Wu J; Zhao S; Gui L; Zhang X; Zhao M; Peng S
    Oncotarget; 2018 Jan; 9(1):268-281. PubMed ID: 29416612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Holothurian glycosaminoglycan inhibits metastasis via inhibition of P-selectin in B16F10 melanoma cells.
    Yue Z; Wang A; Zhu Z; Tao L; Li Y; Zhou L; Chen W; Lu Y
    Mol Cell Biochem; 2015 Dec; 410(1-2):143-54. PubMed ID: 26318439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthranilic acid based CCK1 receptor antagonists: preliminary investigation on their second "touch point".
    Varnavas A; Lassiani L; Valenta V; Mennuni L; Makovec F; Hadjipavlou-Litina D
    Eur J Med Chem; 2005 Jun; 40(6):563-81. PubMed ID: 15922840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.
    Diaz JA; Wrobleski SK; Alvarado CM; Hawley AE; Doornbos NK; Lester PA; Lowe SE; Gabriel JE; Roelofs KJ; Henke PK; Schaub RG; Wakefield TW; Myers DD
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):829-37. PubMed ID: 25657307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,4-Dihydro-l-phenylalanine-its synthesis and behavior in the phenylalanine ammonia-lyase reaction.
    Skolaut A; Rétey J
    Arch Biochem Biophys; 2001 Sep; 393(2):187-91. PubMed ID: 11556804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 2-[1-(4-chlorophenyl)cyclopropyl]-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic acid (PSI-421), a P-selectin inhibitor with improved pharmacokinetic properties and oral efficacy in models of vascular injury.
    Huang A; Moretto A; Janz K; Lowe M; Bedard PW; Tam S; Di L; Clerin V; Sushkova N; Tchernychev B; Tsao DH; Keith JC; Shaw GD; Schaub RG; Wang Q; Kaila N
    J Med Chem; 2010 Aug; 53(16):6003-17. PubMed ID: 20718494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A class of oral N-[(1S,3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carbonyl]- N'-(amino-acid-acyl)hydrazine: discovery, synthesis, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and 3D QSAR analysis.
    Yao K; Zhao M; Zhang X; Wang Y; Li L; Zheng M; Peng S
    Eur J Med Chem; 2011 Aug; 46(8):3237-49. PubMed ID: 21571404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective mechanisms of adenosine 5'-monophosphate in platelet activation and thrombus formation.
    Fuentes E; Badimon L; Caballero J; Padró T; Vilahur G; Alarcón M; Pérez P; Palomo I
    Thromb Haemost; 2014 Mar; 111(3):491-507. PubMed ID: 24306059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel adhesion function blocking monoclonal antibody to rat/mouse P-selectin generated in the P-selectin-deficient mouse.
    Walter UM; Ayer LM; Wolitzky BA; Wagner DD; Hynes RO; Manning AM; Issekutz AC
    Hybridoma; 1997 Jun; 16(3):249-57. PubMed ID: 9219035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.